Eli Lilly (LLY) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Eli Lilly (LLY) over the last 14 years, with Q4 2025 value amounting to $7.39.
- Eli Lilly's EPS (Weighted Average and Diluted) rose 5143.44% to $7.39 in Q4 2025 from the same period last year, while for Dec 2025 it was $22.95, marking a year-over-year increase of 9598.63%. This contributed to the annual value of $22.95 for FY2025, which is 9598.63% up from last year.
- According to the latest figures from Q4 2025, Eli Lilly's EPS (Weighted Average and Diluted) is $7.39, which was up 5143.44% from $6.21 recorded in Q3 2025.
- Eli Lilly's 5-year EPS (Weighted Average and Diluted) high stood at $7.39 for Q4 2025, and its period low was -$0.06 during Q3 2023.
- In the last 5 years, Eli Lilly's EPS (Weighted Average and Diluted) had a median value of $2.02 in 2023 and averaged $2.67.
- Per our database at Business Quant, Eli Lilly's EPS (Weighted Average and Diluted) plummeted by 10372.67% in 2023 and then soared by 188333.33% in 2024.
- Over the past 5 years, Eli Lilly's EPS (Weighted Average and Diluted) (Quarter) stood at $1.89 in 2021, then rose by 13.23% to $2.14 in 2022, then rose by 13.08% to $2.42 in 2023, then skyrocketed by 101.65% to $4.88 in 2024, then surged by 51.43% to $7.39 in 2025.
- Its last three reported values are $7.39 in Q4 2025, $6.21 for Q3 2025, and $6.29 during Q2 2025.